Oxford Drug Design Limited

Royaume‑Uni

Commandez votre montre hebdomadaire Oxford Drug Design Limited
Quantité totale PI 10
Rang # Quantité totale PI 157 866
Note d'activité PI 1,7/5.0    7
Rang # Activité PI 135 834

Brevets

Marques

3 0
3 0
4 0
0
 
Dernier brevet 2025 - 2-amino-n-(oxo-aryl-lambda6-sulf...
Premier brevet 2016 - N-acyl-arylsulfonamide derivativ...

Derniers inventions, produits et services

2024 Invention 2-amino-n-(oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use. NN-(oxo-...
2020 Invention 6-sulfanylidene)acetamide compounds and their therapeutic use. 6-sulfanylidene)acetamide compound...
Invention 2-amino-n-(amino-oxo-aryl-lambda6-sulfanylidene)acetamide compounds and their therapeutic use. Th...
2017 Invention 2-amino-n-(arylsulfinyl)-acetamide compounds as inhibitors of bacterial aminoacyl-trna synthetase...
2016 Invention N-acyl-arylsulfonamide derivatives as aminoacyl-trna synthetase inhibitors. The present invention...
Invention Novel n-acyl-arylsulfonamide derivatives as aminoacyl-trna synthetase inhibitors. The present inv...